Three-dimensional perfused tumour spheroid model for anti-cancer drug screening
<strong>Objective</strong> To build up an in vitro perfused three-dimensional (3D) spheroid model based on the TissueFlex® system for anti-cancer drug efficacy testing, to closer mimic avascular micro-tissues with inherent oxygen, nutrient and metabolite gradients, and to provide more ac...
Main Authors: | , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Netherlands
2016
|
_version_ | 1826305577816424448 |
---|---|
author | Wan, X Li, Z Ye, H Cui, Z |
author_facet | Wan, X Li, Z Ye, H Cui, Z |
author_sort | Wan, X |
collection | OXFORD |
description | <strong>Objective</strong> To build up an in vitro perfused three-dimensional (3D) spheroid model based on the TissueFlex® system for anti-cancer drug efficacy testing, to closer mimic avascular micro-tissues with inherent oxygen, nutrient and metabolite gradients, and to provide more accurate prediction of drug toxicity and efficacy than traditional in vitro tumour models in conventional static culture well plates. <strong>Results</strong> The perfused cancer spheroid model showed higher cell viability and increased diameter of spheroid over a relatively long culture period (17 days). Three anti-cancer drugs with different cytotoxic mechanisms were tested. In perfusion, lower cytotoxicity was observed for traditional cytotoxic drug 5-fluorouracil (5-FU), and microtubule-interfering Paclitaxel showed more spheroid integrity interruption. For the hypoxic-dependent drug, tirapazamine (TPZ), there was no significant difference observed between static and perfusion cultures. <strong>Conclusion</strong> The perfused cancer spheroid model showed higher cell viability and increased diameter of spheroid over a relatively long culture period (17 days). Three anti-cancer drugs with different cytotoxic mechanisms were tested. In perfusion, lower cytotoxicity was observed for traditional cytotoxic drug 5-fluorouracil (5-FU), and microtubule-interfering Paclitaxel showed more spheroid integrity interruption. For the hypoxic-dependent drug, tirapazamine (TPZ), there was no significant difference observed between static and perfusion cultures. |
first_indexed | 2024-03-07T06:34:57Z |
format | Journal article |
id | oxford-uuid:f747f830-ad52-4d0c-9921-ce9ada246c64 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:34:57Z |
publishDate | 2016 |
publisher | Springer Netherlands |
record_format | dspace |
spelling | oxford-uuid:f747f830-ad52-4d0c-9921-ce9ada246c642022-03-27T12:41:33ZThree-dimensional perfused tumour spheroid model for anti-cancer drug screeningJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f747f830-ad52-4d0c-9921-ce9ada246c64EnglishSymplectic Elements at OxfordSpringer Netherlands2016Wan, XLi, ZYe, HCui, Z<strong>Objective</strong> To build up an in vitro perfused three-dimensional (3D) spheroid model based on the TissueFlex® system for anti-cancer drug efficacy testing, to closer mimic avascular micro-tissues with inherent oxygen, nutrient and metabolite gradients, and to provide more accurate prediction of drug toxicity and efficacy than traditional in vitro tumour models in conventional static culture well plates. <strong>Results</strong> The perfused cancer spheroid model showed higher cell viability and increased diameter of spheroid over a relatively long culture period (17 days). Three anti-cancer drugs with different cytotoxic mechanisms were tested. In perfusion, lower cytotoxicity was observed for traditional cytotoxic drug 5-fluorouracil (5-FU), and microtubule-interfering Paclitaxel showed more spheroid integrity interruption. For the hypoxic-dependent drug, tirapazamine (TPZ), there was no significant difference observed between static and perfusion cultures. <strong>Conclusion</strong> The perfused cancer spheroid model showed higher cell viability and increased diameter of spheroid over a relatively long culture period (17 days). Three anti-cancer drugs with different cytotoxic mechanisms were tested. In perfusion, lower cytotoxicity was observed for traditional cytotoxic drug 5-fluorouracil (5-FU), and microtubule-interfering Paclitaxel showed more spheroid integrity interruption. For the hypoxic-dependent drug, tirapazamine (TPZ), there was no significant difference observed between static and perfusion cultures. |
spellingShingle | Wan, X Li, Z Ye, H Cui, Z Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title | Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title_full | Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title_fullStr | Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title_full_unstemmed | Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title_short | Three-dimensional perfused tumour spheroid model for anti-cancer drug screening |
title_sort | three dimensional perfused tumour spheroid model for anti cancer drug screening |
work_keys_str_mv | AT wanx threedimensionalperfusedtumourspheroidmodelforanticancerdrugscreening AT liz threedimensionalperfusedtumourspheroidmodelforanticancerdrugscreening AT yeh threedimensionalperfusedtumourspheroidmodelforanticancerdrugscreening AT cuiz threedimensionalperfusedtumourspheroidmodelforanticancerdrugscreening |